{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,3]],"date-time":"2026-09-03T17:25:15Z","timestamp":1788456315564,"version":"build-2803163510"},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,3,17]],"date-time":"2020-03-17T00:00:00Z","timestamp":1584403200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2020,3,17]],"date-time":"2020-03-17T00:00:00Z","timestamp":1584403200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Postgraduate Research & Practice Innovation Program of Jiangsu Province","award":["SJCX17-0644"],"award-info":[{"award-number":["SJCX17-0644"]}]},{"name":"Nantong city social and people's livelihood science and technology key poject","award":["MS22019001"],"award-info":[{"award-number":["MS22019001"]}]},{"name":"The scientific research program of Jiangsu Province Health Department","award":["H201423"],"award-info":[{"award-number":["H201423"]}]},{"name":"Jiangsu Province Maternal and Child Health Research Project","award":["F201751"],"award-info":[{"award-number":["F201751"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur J Med Res"],"published-print":{"date-parts":[[2020,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec><jats:title>Background<\/jats:title><jats:p>Kawasaki disease (KD) is a common, yet unknown etiology disease in Asian countries, which causes acquired heart disease in childhood. It is characterized by an inflammatory acute febrile vasculitis of medium-sized arteries, particularly the coronary arteries. High-mobility group box-1 protein (HMGB1) is a non-histone chromosomal-binding protein present in the nucleus of eukaryotic cells, which contains 215 amino acid residues. Although the cellular signal transduction mechanisms of HMGB1 are currently unclear, the important role of the receptor for advanced glycation end-products (RAGE), the main receptor for HMGB1 has been reported in detail. The purpose of our study was to verify the mechanism and clinical significance of HMGB1-RAGE in coronary artery injury of Kawasaki disease.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>52 blood samples of patients in KD were collected, and the coronary artery<jats:italic>Z<\/jats:italic>score was calculated according to the echocardiographic results. The<jats:italic>Z<\/jats:italic>score\u2009\u2265\u20092.0 was classified as coronary artery lesions (CAL); otherwise, it was no-coronary artery lesions (NCAL). In addition, the fever group and control group were set. Among them, the fever group were children with fever due to respiratory tract infection at the same time period as KD (heat peak\u2009\u2265\u200938.5\u00a0\u2103). The normal group were children at a routine physical examination in the outpatient clinic of Nantong University and the physical examination center of the child care insurance, and there were no infectious diseases and heart diseases. The serum levels of HMGB1, RAGE, and NF-\u03baB in each group were detected by ELISA. The animal model of KD was established using the New Zealand young rabbits. We used RT-qPCR\/H&amp;E staining\/immunohistochemistry\/ELISA and western blot to detect the level of HMGB1\/RAGE and NF-\u03baB.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>In this study, we found that the HMGB1\/RAGE\/NF-\u03baB axis was elevated in the serum of children with KD. In addition, an animal model of KD was subsequently prepared to examine the pathological changes of the coronary arteries. We found that the serum levels of HMGB1\/RAGE\/NF-\u03baB in rabbits with KD were significantly higher than those of the control group. Moreover, the lumen diameter of the coronary artery was slightly enlarged, and the wall of the tube became thinner and deformed. In addition, the HMGB1\/RAGE\/NF-\u03baB levels in the coronary artery were higher in the rabbits with KD in the acute phase.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusions<\/jats:title><jats:p>On the whole, the findings of this study demonstrate that the expression of HMGB1\/RAGE\/NF-\u03baB is altered at different stages of KD, suggesting that the HMGB1\/RAGE\/NF-\u03baB signaling pathway plays an important role in vascular injury in KD. The results of this study may have important implications for the early warning of coronary artery lesions in KD.<\/jats:p><\/jats:sec>","DOI":"10.1186\/s40001-020-00406-5","type":"journal-article","created":{"date-parts":[[2020,3,17]],"date-time":"2020-03-17T14:02:41Z","timestamp":1584453761000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":21,"title":["Mechanism of HMGB1\u2013RAGE in Kawasaki disease with coronary artery injury"],"prefix":"10.1186","volume":"25","author":[{"given":"Biying","family":"Qian","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hua","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mingye","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tingting","family":"Qin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tao","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianmei","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,3,17]]},"reference":[{"key":"406_CR1","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1542\/peds.54.3.271","volume":"54","author":"T Kawasaki","year":"1974","unstructured":"Kawasaki T, Kosaki F, Okawa S, Shigematsu I, Yanagawa H. A new infantile acute febrile mucocutaneous lymph node syndrome (MLNS) prevailing in Japan. Pediatrics. 1974;54:271\u20136.","journal-title":"Pediatrics"},{"key":"406_CR2","doi-asserted-by":"publisher","first-page":"809","DOI":"10.1002\/ccd.21892","volume":"73","author":"RC Gurofsky","year":"2009","unstructured":"Gurofsky RC, Sabharwal T, Manlhiot C, et al. Arterial complications associated with cardiac catheterization in pediatric patients with a previous history of Kawasaki disease. Catheter Cardiovasc interv. 2009;73:809\u201313.","journal-title":"Catheter Cardiovasc interv"},{"key":"406_CR3","doi-asserted-by":"publisher","first-page":"e2018037","DOI":"10.4084\/mjhid.2018.037","volume":"10","author":"D Buonsenso","year":"2018","unstructured":"Buonsenso D, Cristaldi S, Reale A, de Jacobis IT, Granata L, Marchesi A. Very early development and recognition of coronary involvement in a febrile infant with typical signs of Kawasaki disease. Mediterr J Hematol Infect Dis. 2018;10:e2018037.","journal-title":"Mediterr J Hematol Infect Dis"},{"key":"406_CR4","first-page":"e201726","volume":"2017","author":"MS ElGuindy","year":"2017","unstructured":"ElGuindy MS, ElGuindy AM. Aneurysmal coronary artery disease: an overview. Global Cardiol Sci Pract. 2017;2017:e201726.","journal-title":"Global Cardiol Sci Pract"},{"key":"406_CR5","first-page":"209","volume":"38","author":"N Chantasiriwan","year":"2018","unstructured":"Chantasiriwan N, Silvilairat S, Makonkawkeyoon K, Pongprot Y, Sittiwangkul R. Predictors of intravenous immunoglobulin resistance and coronary artery aneurysm in patients with Kawasaki disease. Paediatr Int Child Health. 2018;38:209\u201312.","journal-title":"Paediatr Int Child Health"},{"key":"406_CR6","doi-asserted-by":"publisher","first-page":"217","DOI":"10.21037\/atm.2016.05.36","volume":"4","author":"M Sohun","year":"2016","unstructured":"Sohun M, Shen H. The implication and potential applications of high-mobility group box 1 protein in breast cancer. Ann Trans Med. 2016;4:217.","journal-title":"Ann Trans Med"},{"key":"406_CR7","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1016\/j.smim.2018.02.011","volume":"38","author":"U Andersson","year":"2018","unstructured":"Andersson U, Yang H, Harris H. High-mobility group box 1 protein (HMGB1) operates as an alarmin outside as well as inside cells. Semin Immunol. 2018;38:40\u20138.","journal-title":"Semin Immunol"},{"key":"406_CR8","doi-asserted-by":"publisher","first-page":"e00245","DOI":"10.1016\/j.heliyon.2017.e00245","volume":"3","author":"ML Gougeon","year":"2017","unstructured":"Gougeon ML, Poirier-Beaudouin B, Durant J, et al. HMGB1\/anti-HMGB1 antibodies define a molecular signature of early stages of HIV-associated neurocognitive Is orders (HAND). Heliyon. 2017;3:e00245.","journal-title":"Heliyon"},{"key":"406_CR9","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1016\/j.intimp.2018.05.032","volume":"61","author":"X Liu","year":"2018","unstructured":"Liu X, Xu Q, Mei L, et al. Paeonol attenuates acute lung injury by inhibiting HMGB1 in lipopolysaccharide-induced shock rats. Int Immunopharmacol. 2018;61:169\u201377.","journal-title":"Int Immunopharmacol"},{"key":"406_CR10","doi-asserted-by":"publisher","first-page":"440","DOI":"10.1016\/j.jaci.2013.12.1035","volume":"134","author":"MA Ullah","year":"2014","unstructured":"Ullah MA, Loh Z, Gan WJ, et al. Receptor for advanced glycation end products and its ligand high-mobility group box-1 mediate allergic airway sensitization and airway inflammation. J Allergy Clin Immunol. 2014;134:440\u201350.","journal-title":"J Allergy Clin Immunol"},{"key":"406_CR11","doi-asserted-by":"publisher","first-page":"1319","DOI":"10.1159\/000490818","volume":"47","author":"H Wu","year":"2018","unstructured":"Wu H, Li R, Pei LG, et al. Emerging role of high mobility group box-1 in thrombosis-related diseases. Cell Physiol Biochem. 2018;47:1319\u201337.","journal-title":"Cell Physiol Biochem"},{"key":"406_CR12","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1080\/08977194.2018.1539393","volume":"36","author":"Y Jiang","year":"2018","unstructured":"Jiang Y, Steinle JJ. HMGB1 inhibits insulin signalling through TLR4 and RAGE in human retinal endothelial cells. Growth Factors (Chur, Switzerland). 2018;36:164\u201371.","journal-title":"Growth Factors (Chur, Switzerland)"},{"key":"406_CR13","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1007\/s12672-018-0342-9","volume":"9","author":"G Palanissami","year":"2018","unstructured":"Palanissami G, Paul SFD. RAGE and its ligands: molecular interplay between glycation, inflammation, and hallmarks of cancer-a review. Horm Cancer. 2018;9:295\u2013325.","journal-title":"Horm Cancer"},{"key":"406_CR14","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1111\/j.1600-0404.2008.01133.x","volume":"120","author":"J Ilzecka","year":"2009","unstructured":"Ilzecka J. Serum-soluble receptor for advanced glycation end product levels in patients with amyotrophic lateral sclerosis. Acta Neurol Scand. 2009;120:119\u201322.","journal-title":"Acta Neurol Scand"},{"key":"406_CR15","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1016\/j.bbamcr.2005.08.006","volume":"1746","author":"Q Ding","year":"2005","unstructured":"Ding Q, Keller JN. Evaluation of rage isoforms, ligands, and signaling in the brain. Biochem Biophys Acta. 2005;1746:18\u201327.","journal-title":"Biochem Biophys Acta"},{"key":"406_CR16","doi-asserted-by":"publisher","first-page":"909","DOI":"10.1016\/j.autrev.2012.03.007","volume":"11","author":"AW de Souza","year":"2012","unstructured":"de Souza AW, Westra J, Limburg PC, Bijl M, Kallenberg CG. HMGB1 in vascular diseases: its role in vascular inflammation and atherosclerosis. Autoimmun Rev. 2012;11:909\u201317.","journal-title":"Autoimmun Rev"},{"key":"406_CR17","unstructured":"Yarui JJL: The expression and clinical significance of high mobility group protein B1 in KD. China Modern Doctor. 2009; 47, Issue 15"},{"key":"406_CR18","doi-asserted-by":"publisher","first-page":"2521","DOI":"10.1253\/circj.CJ-66-0096","volume":"78","author":"Jcs Joint working group","year":"2014","unstructured":"Jcs Joint working group. Guidelines for diagnosis and management of cardiovascular sequelae in Kawasaki disease (JCS 2013). Digest version. Circ J. 2014;78:2521\u201362.","journal-title":"Circ J"},{"key":"406_CR19","doi-asserted-by":"publisher","first-page":"242","DOI":"10.1007\/s00246-009-9599-7","volume":"31","author":"C Manlhiot","year":"2010","unstructured":"Manlhiot C, Millar K, Golding F, McCrindle BW. Improved classification of coronary artery abnormalities based only on coronary artery z-scores after Kawasaki disease. Pediatr Cardiol. 2010;31:242\u20139.","journal-title":"Pediatr Cardiol"},{"key":"406_CR20","first-page":"690","volume":"24","author":"XF Li","year":"2015","unstructured":"Li XF, Zheng P. Xu L and Su Q [The influence of autoclave sterilization on surface characteristics and cyclic fatigue resistance of 3 nickel-titanium rotary instruments]. Shanghai kou qiang yi xue = Shanghai J Stomatol. 2015;24:690\u20135.","journal-title":"Shanghai kou qiang yi xue = Shanghai J Stomatol"},{"key":"406_CR21","doi-asserted-by":"publisher","first-page":"e927","DOI":"10.1161\/CIR.0000000000000484","volume":"135","author":"BW McCrindle","year":"2017","unstructured":"McCrindle BW, Rowley AH, Newburger JW, et al. Diagnosis, treatment, and long-term management of kawasaki disease: a scientific statement for health professionals from the american heart association. Circulation. 2017;135:e927\u2013e999999.","journal-title":"Circulation"},{"key":"406_CR22","doi-asserted-by":"publisher","first-page":"679","DOI":"10.1177\/000331979504600806","volume":"46","author":"Z Onouchi","year":"1995","unstructured":"Onouchi Z, Ikuta K, Nagamatsu K, Tamiya H, Sakakibara Y, Ando M. Coronary artery aneurysms develop in weanling rabbits with serum sickness but not in mature rabbits. An experimental model for Kawasaki disease in humans. Angiology. 1995;46:679\u201387.","journal-title":"Angiology"},{"key":"406_CR23","doi-asserted-by":"publisher","first-page":"1738","DOI":"10.1016\/j.jacc.2015.12.073","volume":"67","author":"JW Newburger","year":"2016","unstructured":"Newburger JW, Takahashi M, Burns JC. Kawasaki Disease. J Am Coll Cardiol. 2016;67:1738\u201349.","journal-title":"J Am Coll Cardiol"},{"key":"406_CR24","doi-asserted-by":"publisher","first-page":"C917","DOI":"10.1152\/ajpcell.00401.2005","volume":"290","author":"JS Park","year":"2006","unstructured":"Park JS, Gamboni-Robertson F, He Q, et al. High mobility group box 1 protein interacts with multiple toll-like receptors. Am J Physiol Cell Physiol. 2006;290:C917\u2013924.","journal-title":"Am J Physiol Cell Physiol"},{"key":"406_CR25","doi-asserted-by":"publisher","first-page":"282","DOI":"10.1016\/j.bbrc.2018.09.002","volume":"505","author":"C Liu","year":"2018","unstructured":"Liu C, Kong X, Wu X, et al. Alleviation of a disintegrin and metalloprotease 10 (ADAM10) on thromboangiitis obliterans involves the HMGB1\/RAGE\/ NF-kappaB pathway. Biochem Biophys Res Commun. 2018;505:282\u20139.","journal-title":"Biochem Biophys Res Commun"},{"key":"406_CR26","doi-asserted-by":"publisher","first-page":"353","DOI":"10.4149\/neo_2015_061","volume":"62","author":"P Tesarova","year":"2015","unstructured":"Tesarova P, Cabinakova M, Mikulova V, Zima T, Kalousova M. RAGE and its ligands in cancer\u2014culprits, biomarkers, or therapeutic targets? Neoplasma. 2015;62:353\u201364.","journal-title":"Neoplasma"},{"key":"406_CR27","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1080\/03009740802144143","volume":"37","author":"T Hoshina","year":"2008","unstructured":"Hoshina T, Kusuhara K, Ikeda K, Mizuno Y, Saito M, Hara T. High mobility group box 1 (HMGB1) and macrophage migration inhibitory factor (MIF) in Kawasaki disease. Scand J Rheumatol. 2008;37:445\u20139.","journal-title":"Scand J Rheumatol"},{"key":"406_CR28","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1111\/cei.12422","volume":"178","author":"AW deSouza","year":"2014","unstructured":"deSouza AW, Abdulahad WH, Sosicka P, et al. Are urinary levels of high mobility group box 1 markers of active nephritis in anti-neutrophil cytoplasmic antibody-associated vasculitis? Clin Exp Immunol. 2014;178:270\u20138.","journal-title":"Clin Exp Immunol"},{"key":"406_CR29","doi-asserted-by":"publisher","first-page":"1057","DOI":"10.1016\/j.autrev.2015.07.010","volume":"14","author":"C Wang","year":"2015","unstructured":"Wang C, de Souza AW, Westra J, et al. Emerging role of high mobility group box 1 in ANCA-associated vasculitis. Autoimmun Rev. 2015;14:1057\u201365.","journal-title":"Autoimmun Rev"},{"key":"406_CR30","doi-asserted-by":"publisher","first-page":"1016","DOI":"10.1038\/s41598-018-19310-4","volume":"8","author":"H Nakaoka","year":"2018","unstructured":"Nakaoka H, Hirono K, Yamamoto S, et al. MicroRNA-145-5p and microRNA-320a encapsulated in endothelial microparticles contribute to the progression of vasculitis in acute Kawasaki Disease. Sci Rep. 2018;8:1016.","journal-title":"Sci Rep"},{"key":"406_CR31","doi-asserted-by":"publisher","first-page":"R251","DOI":"10.1186\/ar4094","volume":"14","author":"Y Qi","year":"2012","unstructured":"Qi Y, Gong F, Zhang Q, Xie C, Wang W, Fu S. Reverse regulation of soluble receptor for advanced glycation end products and proinflammatory factor resistin and S100A12 in Kawasaki disease. Arthritis Res Ther. 2012;14:R251.","journal-title":"Arthritis Res Ther"},{"key":"406_CR32","doi-asserted-by":"publisher","first-page":"472","DOI":"10.1097\/SHK.0000000000001032","volume":"50","author":"H Wang","year":"2018","unstructured":"Wang H, Wang T, Yuan Z, et al. Role of receptor for advanced glycation end products in regulating lung fluid balance in lipopolysaccharide-induced acute lung injury and infection-related acute respiratory distress syndrome. Shock (Augusta, Ga.). 2018;50:472\u201382.","journal-title":"Shock (Augusta, Ga.)"}],"container-title":["European Journal of Medical Research"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s40001-020-00406-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s40001-020-00406-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s40001-020-00406-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,10,18]],"date-time":"2022-10-18T23:50:25Z","timestamp":1666137025000},"score":1,"resource":{"primary":{"URL":"https:\/\/eurjmedres.biomedcentral.com\/articles\/10.1186\/s40001-020-00406-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,3,17]]},"references-count":32,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,12]]}},"alternative-id":["406"],"URL":"https:\/\/doi.org\/10.1186\/s40001-020-00406-5","relation":{},"ISSN":["2047-783X"],"issn-type":[{"value":"2047-783X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,3,17]]},"assertion":[{"value":"24 June 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 February 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 March 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The study protocol was approved by the Institution Review Board of The Affiliated Hospital of Nantong University. Informed consent was obtained from the parents. And the Laboratory Animal Ethics Committee of Nantong University approved the design of this study too.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"The authors declare that they have no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}}],"article-number":"8"}}